397 related articles for article (PubMed ID: 30744139)
41. Monitoring minimal residual disease in acute leukemia: Technical challenges and interpretive complexities.
Chen X; Wood BL
Blood Rev; 2017 Mar; 31(2):63-75. PubMed ID: 27742133
[TBL] [Abstract][Full Text] [Related]
42. BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation?
Zagaria A; Anelli L; Casieri P; Coccaro N; Tota G; Minervini CF; Minervini A; Impera L; Brunetti C; Orsini P; Cellamare A; Specchia G; Albano F
Leuk Lymphoma; 2014 Sep; 55(9):2199-201. PubMed ID: 24325634
[No Abstract] [Full Text] [Related]
43. Role of long non-coding RNAs in normal and malignant hematopoiesis.
Wei P; Han B; Chen Y
Sci China Life Sci; 2013 Oct; 56(10):867-75. PubMed ID: 24030284
[TBL] [Abstract][Full Text] [Related]
44. The stem cell-specific long non-coding RNAs in leukemia.
Farzaneh M; Najafi S; Sheykhi-Sabzehpoush M; Nezhad Dehbashi F; Anbiyaee O; Nasrolahi A; Azizidoost S
Clin Transl Oncol; 2023 Feb; 25(2):345-351. PubMed ID: 36168086
[TBL] [Abstract][Full Text] [Related]
45. Expression Analysis of PVT1, CCDC26, and CCAT1 Long Noncoding RNAs in Acute Myeloid Leukemia Patients.
Izadifard M; Pashaiefar H; Yaghmaie M; Montazeri M; Sadraie M; Momeny M; Jalili M; Ahmadvand M; Ghaffari SH; Mohammadi S; Alimoghaddam K; Ghavamzadeh A
Genet Test Mol Biomarkers; 2018 Oct; 22(10):593-598. PubMed ID: 30222365
[TBL] [Abstract][Full Text] [Related]
46. Novel drug targets in acute leukemia.
Stock W
Clin Adv Hematol Oncol; 2015 Aug; 13(8):493-5. PubMed ID: 26351809
[No Abstract] [Full Text] [Related]
47. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
48. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
[TBL] [Abstract][Full Text] [Related]
49. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA expression in acute lymphoblastic leukemia: A systematic review.
Lobo-Alves SC; Oliveira LA; Kretzschmar GC; Valengo AE; Rosati R
Crit Rev Oncol Hematol; 2024 Apr; 196():104290. PubMed ID: 38341118
[TBL] [Abstract][Full Text] [Related]
51. The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA.
Mangiavacchi A; Sorci M; Masciarelli S; Larivera S; Legnini I; Iosue I; Bozzoni I; Fazi F; Fatica A
Oncotarget; 2016 Sep; 7(37):60155-60168. PubMed ID: 27517498
[TBL] [Abstract][Full Text] [Related]
52. Molecular biology strategies to detect residual disease.
Garcés-Eisele J
Hematology; 2012 Apr; 17 Suppl 1():S66-8. PubMed ID: 22507783
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression.
Hirano T; Yoshikawa R; Harada H; Harada Y; Ishida A; Yamazaki T
Mol Cancer; 2015 Apr; 14():90. PubMed ID: 25928165
[TBL] [Abstract][Full Text] [Related]
54. Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia.
Spanaki A; Linardakis E; Perdikogianni C; Stiakaki E; Morotti A; Cilloni D; Kalmanti M
Leuk Res; 2007 Apr; 31(4):570-2. PubMed ID: 16876863
[TBL] [Abstract][Full Text] [Related]
55. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
[TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNAs and MYC association in hematological malignancies.
Benetatos L; Benetatou A; Vartholomatos G
Ann Hematol; 2020 Oct; 99(10):2231-2242. PubMed ID: 32621182
[TBL] [Abstract][Full Text] [Related]
57. Long noncoding RNAs in cervical cancer.
Shi D; Zhang C; Liu X
J Cancer Res Ther; 2018; 14(4):745-753. PubMed ID: 29970647
[TBL] [Abstract][Full Text] [Related]
58. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
Chandra Gupta S; Nandan Tripathi Y
Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
[TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNAs in haematological malignancies.
Garitano-Trojaola A; Agirre X; Prósper F; Fortes P
Int J Mol Sci; 2013 Jul; 14(8):15386-422. PubMed ID: 23887658
[TBL] [Abstract][Full Text] [Related]
60. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
